May 02, 2022
In a recent study, magnesum L- threonate (Magtein®) is looked at in a randomized, double-blind, placebo-controlled, comparator trial on quality of life, specifically related to levels of stress, anxiety, fear, and other indicators. The objective was to determine if supplementation with Magetein® improves anxiety and/or stress in healthy adults.
In an article authored by Nutrasource Director of Scientific Affairs, Susan J Hewlings, and NPA Senior Vice President of Scientific and Regulatory Affairs, Douglas S Kalman, we learn that there were significant improvements to perceived stress and anxiety levels among participants receiving Magtein®.
While more research in this area is warranted, the associated impact on quality of life with supplementation of Magtein® is encouraging.
“Given the fact that Magnesium is a cofactor over 300 biochemical reactions in the body, it is expected that brain bioavailable Magtein’s function will not be limited to cognition, but can be extended to many other areas,” says Jennifer Gu, Director of R&D at AIDP. “This study demonstrated Magtein’s benefits in the stress/anxiety support in older adults, providing evidence that it is not only shown mechanistically in animal studies, but also in human clinicals. With demonstrated scientific expertise, we appreciate Nutrasource’s assistance in authoring the publication. They delivered excellent service with a timely fashion and a high scientific standard. We highly recommend their team.”
To learn more about Magtein® and this study, view publication